Measuring double awareness in patients with advanced cancer: A preliminary scale development study
Affiliation
Department of Psychiatry, The University of ArizonaDepartment of Psychology, The University of Arizona
Issue Date
2023-12-21Keywords
Advanced cancerDeath contemplation
Double awareness
End of life
Life engagement
Living with cancer
Meaning
Oncology
Palliative care
Scale development
Metadata
Show full item recordPublisher
Cambridge University PressCitation
McConnell MH, Miljanovski M, Rodin G, O’Connor MF (2023). Measuring double awareness in patients with advanced cancer: A preliminary scale development study. Palliative and Supportive Care. https://doi.org/10.1017/S1478951523001669Journal
Palliative and Supportive CareRights
© The Author(s), 2023. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons AttributionNonCommercial-NoDerivatives licence.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background Individuals with advanced cancer face the challenge of living meaningfully while also preparing for end of life. The ability to sustain this duality, called "double awareness,"may reflect optimal psychological adaptation, but no psychometric scale exists to measure this construct. Objectives The purpose of this study was to develop a novel scale to measure double awareness in patients living with advanced cancer. Methods Guided by best practices for scale development, this study addresses the first three of nine steps in instrument development, including domain clarification and item generation, establishment of content validity of the items, and pre-testing of the items with patients. Results Instrument development resulted in a 41-item measure with two dimensions titled "life engagement"and "death contemplation."Items retained in the measure displayed face validity and were found to be both acceptable by patients and relevant to their lived experience. Significance of results The results of this scale development study will allow for full validation of the measure and future use in clinical and research settings. This novel measure of double awareness will have clinical utility and relevance in a variety of settings where patients with advanced cancer are treated. © The Author(s), 2023. Published by Cambridge University Press.Note
Open access articleISSN
1478-9515Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1017/S1478951523001669
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s), 2023. Published by Cambridge University Press. This is an Open Access article, distributed under the terms of the Creative Commons AttributionNonCommercial-NoDerivatives licence.

